EGS P08 Endoscopic ultrasound-guided transmural gallbladder drainage – Who can benefit?


 
 
 Endoscopic ultrasound-guided gallbladder drainage (EGBD, cholecysto-duodenostomy) is a safe alternative to percutaneous gallbladder drainage (PGBD) for treatment of acute cholecystitis, and avoids morbidity from external drains. However it may complicate attempts at future cholecystectomy. We aimed to identify a patient subgroup that would not be fit for surgery in the future and therefore should be considered for EGBD.
 
 
 
 Patients with cholecystitis were identified retrospectively using hospital coding (2012–2022). Additional codes for cholecystectomy and percutaneous drainage were used to identify subgroups. Patient characteristics were also collected. Charleston comorbidity index (CCI) and APACHEII score were calculated where data were available. Statistical analyses were performed in R (Welch t-test). Data are displayed (mean LC vs mean NLC, p value).
 
 
 
 5653 patients with cholecystitis were identified (3765 LC, 66.6%). 53(0.94%) underwent PGBD. 23(43%) subsequently underwent LC. Patients in the LC group were younger (62.2vs74 p=0.002) and had a lower CCI (3.6vs5.9 p=0.001) compared to the non-operative (NLC) group. APACHE scores were calculated in 40/53 patients (16 LC, 24 NLC) and were similar between groups (8.5vs10.6 p=0.76). BMI was calculated in 41 patients (18 LC, 23 NLC) and was not significantly different (30.0vs30.6 p=0.19).
 
 
 
 We have identified an older, more comorbid subgroup of patients with severe cholecystitis who are unlikely to be fit for surgery and could potentially benefit from definitive EGBD. There remains a place for PGBD in patients that will eventually become suitable for LC.
